Brenton K. Ahrens - Jun 23, 2021 Form 4 Insider Report for Iterum Therapeutics plc (ITRM)

Role
Director
Signature
/s/ Brenton K. Ahrens
Stock symbol
ITRM
Transactions as of
Jun 23, 2021
Transactions value $
$0
Form type
4
Date filed
6/25/2021, 04:05 PM
Next filing
Mar 29, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ITRM Stock Option (Right to Buy) Award $0 +64.7K $0.00 64.7K Jun 23, 2021 Ordinary Shares 64.7K $2.01 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Subject to the reporting person providing continuous service to the Issuer and the other terms and conditions of the Issuer's Amended and Restated 2018 Equity Incentive Plan, as amended, the shares subject to this option shall vest in full on June 23, 2022.